The insurance drug price of new medicine is equivalent to 44.4% of the OECD average

It was confirmed that the insurance drug price of new medicine, which was registered after the positive list policy took effect, was less than half of the average price of the OECD countries. The price was equivalent to 44.4% of the OECD average by applying exchange rate and 59.9% by applying purchasing power parity (PPP).

The price of orphan drug was slightly higher than OTC medication that s...